产品货号:
Z20315
中文名称:
KLRA2抗体
英文名称:
Anti-KLRA2 Antibody
产品规格:
0.1mg
发货周期:
1~3天
产品价格:
询价
| 抗体名称 | Anti-KLRA2 Antibody |
| 指标别名 | Ly49b,Klra30,Ly49-b,Ly49b,Killer cell lectin-like receptor 2,Lymphocyte antigen 49b,Ly-49b |
| 克隆性 | Polyclonal |
| 检验物种 | mouse,rat |
| 应用范围 | ELISA,WB,IHC,IF |
| 基因名称 | KLRA2 |
| 抗体来源 | Rabbit |
| 抗体类型 | IgG |
| 免疫原 | KLRA2 antibody was raised against a 14 amino acid synthetic peptide near the carboxy terminus of mouse KLRA2.The immunogen is located within the last 50 amino acids of KLRA2. |
| 计算分子量 | 34kDa |
| 成分 | KLRA2 Antibody is supplied in PBS containing 0.02% sodium azide. |
| 纯化方式 | KLRA2 Antibody is affinity chromatography purified via peptide column. |
| 浓度 | 1mg/mL |
| 产品形态 | 溶液 |
| 保存条件 | 4℃可保存3个月,-20℃可保存1年。 |
| 背景资料 | KLRA2 (also known as Ly49B) is a member of the LY49 family of receptors in Natural Killer (NK) cells that bind to major histocompatibility complex (MHC) class 1.These proteins are classified as either activating or inhibitory receptors based on whether they possess an immunoreceptor tyrosine-based inhibitory motif (ITIM) in their cytoplasmic region (for inhibitory receptors),or an immunoreceptor tyrosine-based activation motif (ITAM) that transmits activating signals resulting in phosphorylation of several substrates.KLRA2 is thought to be an inhibitory receptor and associates with the protein tyrosine phosphatases SHP1,SHP2,and SHIP in transfected cells.This antibody is predicted to not cross-react with other LY49 receptors. |
| Uniprot ID | Q60660 |
| 基因名全称 | Killer cell lectin-like receptor,subfamily A,member 2 |
| 蛋白名全称 | Killer cell lectin-like receptor,subfamily A,member 2 |
| 推荐稀释比 | KLRA2 antibody can be used for detection of KLRA2 by Western blot at 0.5 ~ 1μg/mL.Antibody can also be used for immunohistochemistry starting at 2.5μg/mL.For immunofluorescence start at 20μg/mL.Antibody validated:Western Blot in mouse samples and Immunohistochemistry in mouse samples.All other applications and species not yet tested. |
相关搜索:KLRA2抗体,KLRA2多抗,Anti-KLRA2 Antibody
